Prevacid Follow-On NDA To Be Submitted In 2008
TAP is preparing to start Phase III clinical trials for TAK-390MR, an enantiomer of Prevacid (lansoprazole).
TAP is preparing to start Phase III clinical trials for TAK-390MR, an enantiomer of Prevacid (lansoprazole).